BCB-276 cell therapy for pediatric brain cancer gets new FDA status
BCB-276, an experimental cell therapy that Brainchild Bio…
Gliomas are a group of brain tumors that arise from glial cells, a type of support cell of the central nervous system, or CNS, which comprises the brain and spinal cord. They make up about one-quarter of all tumors that start in the brain (primary brain tumors), occurring in about 6.6 per 100,000 people every year. They also account for more than 80% of all malignant, or cancerous, brain tumors.
Read moreTreatment for gliomas, a diverse group of tumors that form in the brain and spinal cord, can involve a variety of approaches, including surgery, radiation therapy, and chemotherapy, as well as a range of supportive treatments.
Read moreBCB-276, an experimental cell therapy that Brainchild Bio…
Optieum Biotechnologies and Genezen are teaming up…
Contract development and manufacturing organization Viralgen said it has…
Each May marks Brain Tumor Awareness Month, with annual…
The U.S. Food and Drug Administration (FDA) has granted…
The LY6H and GRM3 proteins could serve as potential…